Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on March 11, 2013, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, the following acquisitions occurred:
- Acquisition of 2 Ordinary Shares under the personal contribution element.
- Acquisition of 2 Ordinary Shares under the matching element (Company contribution).
The purchase price was 1490.69 pence per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the total number of shares acquired by Mr. P C Thomson and Mrs. K Thomson (4 shares total).
- Confirm the transaction price of 1490.69 pence per share.
- Note that this filing does not contain financial performance data for the period.